Heidi
by Heidi Health
Heidi is an AI clinical documentation assistant for healthcare professionals. It records patient visits with consent, drafts structured clinical notes, and can generate related documents such as letters and patient summaries.
Why Abandoned
Heidi Health’s website is operational and continues to offer the clinical documentation product. The company also announced a Series B financing in October 2024, supporting continued expansion.
🩺 Health Signals
- HTTP Status
- 200
- Response
- —
- SSL
- —
- Confidence
- 96%
- Domain expires
- —
- Last content change
- —
- Last tweet
- —
- API status
- —
📅 Timeline
Heidi Health founded
Thomas Kelly, Yu Liu, and Will Gao founded the Australian healthcare technology company that became Heidi Health.
Series A funding announced
Heidi Health announced AUD 10 million in Series A funding led by Blackbird Ventures, with participation from Hostplus, Vesta, Archangel Ventures, Possible Ventures, and Daniel Ventures.
Free AI medical scribe launched
Heidi Health announced a free version of its AI medical scribe for clinicians, positioning core clinical note generation as broadly accessible.
Series B funding announced
Heidi Health announced AUD 30 million in Series B funding led by Headline, with existing investors participating, to support product development and international growth.
🔄 Alternatives to Heidi
Fireflies.ai
🟢ActiveAI notetaker that automatically records, transcribes, and analyzes voice conversations.
Otter.ai
🟢ActiveAI meeting assistant that records, transcribes, and summarizes meetings in real-time.
Tactiq
🟢ActiveTactiq is an AI meeting assistant and browser extension that transcribes Google Meet, Zoom, and Microsoft Teams calls. It can generate summaries, action items, follow-up text, and answers based on meeting transcripts.
Zoom AI Companion
🟢ActiveZoom AI Companion is a generative AI assistant built into Zoom Workplace. It can summarize meetings, identify action items, help draft chat and email messages, and answer questions using permitted workplace context.
🪦 Other dead Healthcare tools
Kheiron Mia
🟡Acquired / MergedMia is Kheiron Medical Technologies’ artificial intelligence platform for breast-screening mammography. It supports radiologists by analyzing mammograms and identifying cases that may warrant further review.
MaxQ AI ACCIPIO
🟠Possibly DeadACCIPIO was MaxQ AI's clinical AI platform for analyzing non-contrast head CT scans and prioritizing suspected intracranial hemorrhage cases for radiologist review. It was a triage aid, not a standalone diagnosis system.
Arterys Cardio AI
🟡Acquired / MergedCloud-based cardiac MRI analysis software that used machine learning to assist clinicians with image segmentation, ventricular measurements, and cardiac function assessment. Tempus acquired Arterys in 2022.
Zebra Medical Vision Imaging Analytics
🟡Acquired / MergedAI-based medical imaging analytics developed by Zebra Medical Vision to help identify findings in radiology scans. Nanox acquired Zebra in 2021 and incorporated its software into the Nanox.AI portfolio.
❓ Frequently Asked Questions
What is Heidi Health?
Heidi Health is an AI clinical documentation platform that helps healthcare professionals turn patient consultations into structured clinical notes and related documents.
How does the Heidi AI medical scribe work?
With appropriate patient consent, Heidi captures a consultation, transcribes relevant content, and drafts a clinical note using a clinician-selected or customized template. The clinician remains responsible for reviewing and approving the output.
Is Heidi Health free for doctors and clinicians?
Heidi offers a free plan for core AI scribing, alongside paid plans with additional capabilities. Current limits and pricing should be confirmed on Heidi Health’s official pricing page.
Who founded Heidi Health?
Heidi Health was founded in Australia by Thomas Kelly, Yu Liu, and Will Gao.
Is Heidi Health still active?
Yes. Heidi Health’s official website remains operational, and the company has continued to develop and market its AI clinical documentation platform. Its October 2024 Series B announcement also supports an active status.